His primary areas of investigation include Microbiology, Escherichia coli, Enterobacteriaceae, Antibiotics and Molecular epidemiology. His research in Microbiology is mostly concerned with Drug resistance. He has researched Drug resistance in several fields, including Antibacterial agent, Intensive care medicine, Global health, Beta-lactamase and Gentamicin.
His studies deal with areas such as Genotype and Virulence as well as Escherichia coli. His study in Enterobacteriaceae is interdisciplinary in nature, drawing from both Klebsiella, Outbreak, Enterobacter aerogenes and Bacteria. His research investigates the connection between Antibiotics and topics such as Infection control that intersect with issues in Carbapenem-resistant enterobacteriaceae, Colistin, Tigecycline, β lactamases and Klebsiella spp.
Johann D. D. Pitout mostly deals with Microbiology, Escherichia coli, Klebsiella pneumoniae, Enterobacteriaceae and Plasmid. His Microbiology research is multidisciplinary, relying on both Polymerase chain reaction and Virology. His research integrates issues of Molecular epidemiology, Multilocus sequence typing, Genotype and Virulence in his study of Escherichia coli.
His Klebsiella pneumoniae research includes elements of Bacteremia and Quinolone resistance. Intensive care medicine is closely connected to Internal medicine in his research, which is encompassed under the umbrella topic of Bacteremia. His Enterobacteriaceae research integrates issues from Serratia marcescens, Klebsiella and Bacteria.
His main research concerns Antibiotic resistance, Microbiology, Escherichia coli, Klebsiella pneumoniae and Genetics. The Antibiotic resistance study combines topics in areas such as Ciprofloxacin, Antimicrobial and Environmental health. His work on Gentamicin as part of general Microbiology study is frequently linked to Rapid detection, bridging the gap between disciplines.
His studies in Escherichia coli integrate themes in fields like Pathogen, Molecular epidemiology, Clade and Sequence. The various areas that Johann D. D. Pitout examines in his Klebsiella pneumoniae study include Plasmid, Bacteremia, Internal medicine, Enterobacteriaceae and Drug resistance. His work deals with themes such as Replicon, Genome and Transformation, which intersect with Drug resistance.
Johann D. D. Pitout spends much of his time researching Escherichia coli, Genetics, Klebsiella pneumoniae, Enterobacteriaceae and Gene. His biological study spans a wide range of topics, including Lineage, Functional analysis, Molecular epidemiology, Antibiotic resistance and Phylogenetics. His work focuses on many connections between Molecular epidemiology and other disciplines, such as Pharmacotherapy, that overlap with his field of interest in Microbiology.
His work on Microbiology is being expanded to include thematically relevant topics such as Virulence. His Klebsiella pneumoniae research is multidisciplinary, incorporating elements of Internal medicine and Intensive care unit. Johann D. D. Pitout has included themes like Transformation, Replicon, Genome and Drug resistance in his Enterobacteriaceae study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Johann D D Pitout;Kevin B Laupland.
Lancet Infectious Diseases (2008)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L Silvia Munoz-Price;L Silvia Munoz-Price;Laurent Poirel;Robert A Bonomo;Robert A Bonomo;Mitchell J Schwaber.
Lancet Infectious Diseases (2013)
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Johann D. D. Pitout;Patrice Nordmann;Kevin B. Laupland;Laurent Poirel.
Journal of Antimicrobial Chemotherapy (2005)
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Marie Hélène Nicolas-Chanoine;Jorge Blanco;Véronique Leflon-Guibout;Raphael Demarty.
Journal of Antimicrobial Chemotherapy (2007)
Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15
Teresa M. Coque;Ângela Novais;Alessandra Carattoli;Laurent Poirel.
Emerging Infectious Diseases (2008)
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Johann D. D. Pitout;Patrice Nordmann;Laurent Poirel.
Antimicrobial Agents and Chemotherapy (2015)
A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients
Ronen Ben-Ami;Jesús Rodríguez-Baño;Hande Arslan;Johann D D Pitout.
Clinical Infectious Diseases (2009)
Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4
Gisele Peirano;Johann D.D. Pitout.
International Journal of Antimicrobial Agents (2010)
DETECTION OF PSEUDOMONAS AERUGINOSA PRODUCING METALLO-BETA-LACTAMASES IN A LARGE CENTRALIZED LABORATORY
Johann D. D. Pitout;Daniel B. Gregson;Laurent Poirel;Jo-Ann McClure.
Journal of Clinical Microbiology (2005)
Global dissemination of a multidrug resistant Escherichia coli clone
Nicola K. Petty;Nouri L. Ben Zakour;Mitchell Stanton-Cook;Elizabeth Skippington.
Proceedings of the National Academy of Sciences of the United States of America (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: